Lifecore Biomedical Inc (LFCR)
6.28
-0.29
(-4.41%)
USD |
NASDAQ |
May 10, 16:00
6.296
+0.02
(+0.25%)
Pre-Market: 20:00
Lifecore Biomedical Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2023 | -24.03 |
| February 28, 2023 | 3.361 |
| November 30, 2022 | 1.981 |
| August 31, 2022 | 1.471 |
| May 31, 2022 | 1.573 |
| February 28, 2022 | 0.8294 |
| November 30, 2021 | 1.064 |
| August 31, 2021 | 0.8038 |
| May 31, 2021 | 0.9562 |
| February 28, 2021 | 0.9092 |
| November 30, 2020 | 0.8145 |
| August 31, 2020 | 0.7865 |
| May 31, 2020 | 0.8237 |
| February 29, 2020 | 0.7056 |
| November 30, 2019 | 0.6975 |
| August 31, 2019 | 0.6233 |
| May 31, 2019 | 0.5515 |
| February 28, 2019 | 0.5311 |
| November 30, 2018 | 0.3227 |
| August 31, 2018 | 0.316 |
| May 31, 2018 | 0.2744 |
| February 28, 2018 | 0.2234 |
| November 30, 2017 | 0.2369 |
| August 31, 2017 | 0.2461 |
| May 31, 2017 | 0.2217 |
| Date | Value |
|---|---|
| February 28, 2017 | 0.2178 |
| November 30, 2016 | 0.2349 |
| August 31, 2016 | 0.2415 |
| May 31, 2016 | 0.2721 |
| February 29, 2016 | 0.2787 |
| November 30, 2015 | 0.2141 |
| August 31, 2015 | 0.1827 |
| May 31, 2015 | 0.1947 |
| February 28, 2015 | 0.2328 |
| November 30, 2014 | 0.2254 |
| August 31, 2014 | 0.1945 |
| May 31, 2014 | 0.1693 |
| February 28, 2014 | 0.1807 |
| November 30, 2013 | 0.2023 |
| August 31, 2013 | 0.2176 |
| May 31, 2013 | 0.2479 |
| February 28, 2013 | 0.2707 |
| November 30, 2012 | 0.3114 |
| August 31, 2012 | 0.3487 |
| May 31, 2012 | 0.3939 |
| February 29, 2012 | 0.1116 |
| November 30, 2011 | 0.1243 |
| August 31, 2011 | 0.135 |
| May 31, 2011 | 0.1457 |
| February 28, 2011 | 0.1491 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-24.03
Minimum
May 2023
3.361
Maximum
Feb 2023
-0.3575
Average
0.8237
Median
May 2020
Debt to Equity Ratio Benchmarks
| Aquestive Therapeutics Inc | -0.7929 |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 0.9659 |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 7.228 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 255.15M |
| Total Liabilities (Quarterly) | 256.99M |
| Shareholders Equity (Quarterly) | -1.842M |